You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

AstraZeneca
Moodys
Medtronic
McKinsey
Johnson and Johnson
Mallinckrodt

Last Updated: May 16, 2021

DrugPatentWatch Database Preview

Retinoid Drug Class List

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Drugs in Drug Class: Retinoid

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dr Reddys Labs Ltd ZENATANE isotretinoin CAPSULE;ORAL 202099-002 Mar 25, 2013 AB1 RX No No   Get Started for $10   Get Started for $10   Get Started for $10
Dr Reddys Labs Ltd ZENATANE isotretinoin CAPSULE;ORAL 202099-004 Feb 23, 2015 AB1 RX No No   Get Started for $10   Get Started for $10   Get Started for $10
Dr Reddys Labs Ltd ZENATANE isotretinoin CAPSULE;ORAL 202099-003 Mar 25, 2013 AB1 RX No No   Get Started for $10   Get Started for $10   Get Started for $10
Dr Reddys Labs Ltd ZENATANE isotretinoin CAPSULE;ORAL 202099-001 Mar 25, 2013 AB1 RX No No   Get Started for $10   Get Started for $10   Get Started for $10
Almirall VELTIN clindamycin phosphate; tretinoin GEL;TOPICAL 050803-001 Jul 16, 2010 BX RX Yes Yes   Get Started for $10   Get Started for $10   Get Started for $10
Galderma Labs Lp TRI-LUMA fluocinolone acetonide; hydroquinone; tretinoin CREAM;TOPICAL 021112-001 Jan 18, 2002 RX Yes Yes   Get Started for $10   Get Started for $10 Y   Get Started for $10
Galderma Labs Lp TRI-LUMA fluocinolone acetonide; hydroquinone; tretinoin CREAM;TOPICAL 021112-001 Jan 18, 2002 RX Yes Yes   Get Started for $10   Get Started for $10 Y   Get Started for $10
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
Johnson and Johnson
AstraZeneca
Medtronic
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.